GB1137156A - Improvements in or relating to the manufacture of sustained release pharmaceutical tablets - Google Patents

Improvements in or relating to the manufacture of sustained release pharmaceutical tablets

Info

Publication number
GB1137156A
GB1137156A GB4463266A GB4463266A GB1137156A GB 1137156 A GB1137156 A GB 1137156A GB 4463266 A GB4463266 A GB 4463266A GB 4463266 A GB4463266 A GB 4463266A GB 1137156 A GB1137156 A GB 1137156A
Authority
GB
United Kingdom
Prior art keywords
tablets
substance
release delay
oct
suspended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4463266A
Other languages
English (en)
Inventor
Jorgen Roed Jensen
Morten Benthin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd AS filed Critical Leo Pharmaceutical Products Ltd AS
Publication of GB1137156A publication Critical patent/GB1137156A/en
Expired legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/003—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic followed by coating of the granules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/006—Coating of the granules without description of the process or the device by which the granules are obtained

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB4463266A 1965-10-12 1966-10-06 Improvements in or relating to the manufacture of sustained release pharmaceutical tablets Expired GB1137156A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK522265 1965-10-12

Publications (1)

Publication Number Publication Date
GB1137156A true GB1137156A (en) 1968-12-18

Family

ID=8140572

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4463266A Expired GB1137156A (en) 1965-10-12 1966-10-06 Improvements in or relating to the manufacture of sustained release pharmaceutical tablets

Country Status (11)

Country Link
BE (1) BE688121A (enrdf_load_html_response)
BR (1) BR6683606D0 (enrdf_load_html_response)
CA (1) CA983393A (enrdf_load_html_response)
DE (1) DE1617593A1 (enrdf_load_html_response)
ES (1) ES332215A1 (enrdf_load_html_response)
FI (1) FI48245B (enrdf_load_html_response)
FR (1) FR1602625A (enrdf_load_html_response)
GB (1) GB1137156A (enrdf_load_html_response)
NL (1) NL6614357A (enrdf_load_html_response)
NO (1) NO126201B (enrdf_load_html_response)
SE (1) SE337281C (enrdf_load_html_response)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2231365A1 (enrdf_load_html_response) * 1973-05-29 1974-12-27 Hoffmann La Roche
US5853758A (en) * 1992-01-13 1998-12-29 Pfizer Inc. Preparation of tablets of increased strength
CN110368371A (zh) * 2014-04-08 2019-10-25 越洋医药开发(广州)有限公司 一种新型控释片

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH574245A5 (enrdf_load_html_response) * 1971-06-04 1976-04-15 Boehringer Mannheim Gmbh
FR2383659A1 (fr) * 1977-03-16 1978-10-13 Berri Balzac Procede de preparation de comprimes contenant des substances labiles en microdispersion
US4673527A (en) * 1985-05-20 1987-06-16 Autotrol Corporation Tablet granulation
JPH03232814A (ja) * 1990-02-08 1991-10-16 Shin Etsu Chem Co Ltd 徐放性錠剤の製造方法
DE19729487A1 (de) * 1997-07-10 1999-01-14 Dresden Arzneimittel Verfahren zur Herstellung von Wirkstoff-Zubereitungen mit kontrollierter Freisetzung aus einer Matrix

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2231365A1 (enrdf_load_html_response) * 1973-05-29 1974-12-27 Hoffmann La Roche
US5853758A (en) * 1992-01-13 1998-12-29 Pfizer Inc. Preparation of tablets of increased strength
CN110368371A (zh) * 2014-04-08 2019-10-25 越洋医药开发(广州)有限公司 一种新型控释片

Also Published As

Publication number Publication date
ES332215A1 (es) 1968-05-01
BR6683606D0 (pt) 1973-11-13
FI48245B (enrdf_load_html_response) 1974-04-30
FR1602625A (en) 1971-01-04
NL6614357A (enrdf_load_html_response) 1967-04-13
SE337281C (enrdf_load_html_response) 1975-10-20
NO126201B (enrdf_load_html_response) 1973-01-08
DE1617593A1 (de) 1971-04-29
SE337281B (enrdf_load_html_response) 1971-08-02
CA983393A (en) 1976-02-10
BE688121A (enrdf_load_html_response) 1967-04-12

Similar Documents

Publication Publication Date Title
ES423856A1 (es) Procedimiento para la elaboracion de medicamentos con ce- sion retardada de la sustancia activa en el instestino.
CA1165691A (en) Retarded release pharmaceutical composition and process
US3670065A (en) Process for producing dosage units of a type resembling tablets
US4132753A (en) Process for preparing oral sustained release granules
US3279998A (en) Method of preparing sustained release tablets
US3119742A (en) Method of preparing sustained release pharmaceutical pellets and product thereof
GB906422A (en) Improvements in and relating to prolonged acting pharmaceutical preparations
GB1137156A (en) Improvements in or relating to the manufacture of sustained release pharmaceutical tablets
CA2341646C (en) Method for producing solid dosing forms
ATE66144T1 (de) Herstellungsverfahren fuer arzneimittel mit verzoegerter wirkstoffabgabe.
ES424097A1 (es) Un instrumento y su metodo correspondiente para distribuir material dentro de las trompas de falopio del cuerpo de una hembra.
CA997677A (en) Layered bolus for animal husbandry providing for immediate and sustained release of medicament
GB1179938A (en) Medicinal Sustained-Release Tablets.
WO2005000237B1 (en) Granules containing biologically active substances
GB1178622A (en) Encapsulation Process
NL183890C (nl) Werkwijze voor bereiding van zouten van 5'-fosforzuuresters van pyridoxinederivaten, werkwijze voor de bereiding van een geneesmiddel, alsmede een zo verkregen gevormd geneesmiddel.
BE762716A (fr) Procede de preparation de doses unitaires a l'etat solide pour l'administration de medicaments et produits obtenus
US2895881A (en) Quinidine gluconate sustained medication tablet
GB1340921A (en) Pharmaceutical composition
ES403326A1 (es) Procedimiento para la granulacion de masas para tabletas enforma de polvo.
NO160902B (no) Fremgangsm te for ekstrahering av en vaeske.
NO133220B (enrdf_load_html_response)
NL160556C (nl) Werkwijze voor het bereiden van een veterinair farmaceu- tisch preparaat met bactericide werking op basis van een chinoxaline-1,4-dioxyde-ester, het gevormde preparaat, diervoeder en diervoedertoevoeging alsmede werkwijze voor het bereiden van een chinoxaline-1,4-dioxyde-ester.
GB1241024A (en) Pharmaceutical tablet base and a process for its manufacture
IL23803A (en) There she found a missing Hebrew